We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

8 hedge funds and large institutions have $1.08M invested in TriSalus Life Sciences Warrant in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,938% more capital inflows, than outflows

Capital inflows: $983K | Capital outflows: $48.2K

2.49% more ownership

Funds ownership: 0.71% → 3.2% (+2.5%)

0% more funds holding

Funds holding: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Graypoint LLC
Graypoint LLC
New York
+$983K
2
Clear Street
Clear Street
New York
+$119

Top Sellers

Rank Fund Capital Flow
1
GTS Securities
GTS Securities
Florida
-$13.8K
2
HRT Financial
HRT Financial
New York
-$8.31K
3
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors
South Carolina
-$4.55K
4
Wolverine Asset Management
Wolverine Asset Management
Illinois
-$1.01K

TLSIW Hedge Fund Activity: Q4 2024 in Review

8 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q4 2024, worth a combined $1.08M — up 421% from $208K a quarter earlier.

Fund positioning in TLSIW was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 3 trimmed.

The largest buyer was Graypoint LLC, opening a new position worth an estimated $983K. The largest seller was GTS Securities, exiting entirely with an estimated $13.8K sold.

  • 8 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $1.08M of TriSalus Life Sciences Warrant stock for Q4 2024, up 421% quarter-over-quarter.
  • 2 funds opened new TriSalus Life Sciences Warrant positions in Q4 2024 and 2 closed out, a net change of 0 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q4 2024 was Graypoint LLC, an estimated $983K added.
  • The largest TriSalus Life Sciences Warrant seller in Q4 2024 was GTS Securities, an estimated $13.8K sold.

Based on aggregated 13F filings for Q4 2024.